RecruitingPhase 2NCT03270059

Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System

The Feasibility of Steady State CBV Mapping Using Ferumoxytol Immediately After Gadolinium Enhanced MRI of the CNS


Sponsor

OHSU Knight Cancer Institute

Enrollment

150 participants

Start Date

Oct 6, 2017

Study Type

INTERVENTIONAL

Conditions

Summary

This phase II trial studies how well gadolinium and ferumoxytol magnetic resonance imaging (MRI) work in diagnosing patients with abnormalities in the central nervous system. Diagnostic procedures, such as gadolinium and ferumoxytol MRI, may help find and diagnose abnormalities in the central nervous system.


Eligibility

Min Age: 10 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two different contrast agents (dyes used to improve MRI images) — gadolinium (the standard) and ferumoxytol (an iron-based alternative) — to see which provides better, more detailed images of the brain and nervous system in patients with neurological conditions or brain tumors. **You may be eligible if...** - You are at least 10 years old - You have neurological symptoms (such as headaches, seizures, weakness, or nerve problems), a brain abnormality seen on imaging, or a cancer elsewhere that may have spread to the brain - You are able to have an MRI without sedation **You may NOT be eligible if...** - You are pregnant or breastfeeding - You have a pacemaker, metal implants in your body, or are severely claustrophobic - You have an allergy to gadolinium, iron-based products, or dextran - You have a condition called iron overload (hemochromatosis) - You have three or more drug allergies from different drug classes Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGFerumoxytol

Given IV

DRUGGadolinium

Given IV

PROCEDUREMagnetic Resonance Imaging

Undergo MRI


Locations(1)

OHSU Knight Cancer Institute

Portland, Oregon, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03270059


Related Trials